Latest Breaking News On - Medical subject - Page 1 : comparemela.com

Coronary artery disease (CAD) is one of the leading causes of death worldwide. Atherosclerosis begins in childhood as fatty streaks, progresses with age, and lifestyle influences the progression of atherosclerotic plaque. Over time, with significant narrowing of the blood vessels, blood flow into the coronary arteries is compromised, resulting in various symptoms of coronary heart disease. Many drugs are used in clinical practice to prevent atherosclerotic cardiovascular events in patients with CAD. This review aims to investigate the efficacy and safety of a non-statin novel lipid-lowering drug, bempedoic acid (BDA), an adenosine triphosphate (ATP) citrate lyase inhibitor, in lowering serum low-density lipoprotein cholesterol (LDL-C) levels among patients with CAD. BDA is a new drug that recently got approval for clinical use. Following its discovery, BDA has been researched in order to investigate its role in the treatment of hypercholesterolemia. A search for studies was conducted u

United statesRaman goitAmerican college of cardiologyJoanna briggs instituteElton bryson stephens companyPreferred reporting itemsSystematic reviewsPubmed centralGoogle scholarCoronary artery diseaseCardiovascular diseaseCritical appraisal checklistMultiple systematic reviewsNarrative review articlesRandomized controlled trialsMedical subject